JP2014234369A5 - - Google Patents

Download PDF

Info

Publication number
JP2014234369A5
JP2014234369A5 JP2013117333A JP2013117333A JP2014234369A5 JP 2014234369 A5 JP2014234369 A5 JP 2014234369A5 JP 2013117333 A JP2013117333 A JP 2013117333A JP 2013117333 A JP2013117333 A JP 2013117333A JP 2014234369 A5 JP2014234369 A5 JP 2014234369A5
Authority
JP
Japan
Prior art keywords
molecular weight
improving
ultraviolet rays
hyaluronic acid
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013117333A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014234369A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013117333A priority Critical patent/JP2014234369A/ja
Priority claimed from JP2013117333A external-priority patent/JP2014234369A/ja
Publication of JP2014234369A publication Critical patent/JP2014234369A/ja
Publication of JP2014234369A5 publication Critical patent/JP2014234369A5/ja
Pending legal-status Critical Current

Links

JP2013117333A 2013-06-03 2013-06-03 経口用光老化改善剤 Pending JP2014234369A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013117333A JP2014234369A (ja) 2013-06-03 2013-06-03 経口用光老化改善剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013117333A JP2014234369A (ja) 2013-06-03 2013-06-03 経口用光老化改善剤

Publications (2)

Publication Number Publication Date
JP2014234369A JP2014234369A (ja) 2014-12-15
JP2014234369A5 true JP2014234369A5 (enExample) 2016-05-26

Family

ID=52137322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013117333A Pending JP2014234369A (ja) 2013-06-03 2013-06-03 経口用光老化改善剤

Country Status (1)

Country Link
JP (1) JP2014234369A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230012343A1 (en) * 2019-12-20 2023-01-12 Hitachi High-Tech Corporation Molecular weight marker for electrophoresis, nucleic acid fractionation method and nucleic acid size analysis method
CN121368434A (zh) * 2023-04-17 2026-01-20 富地滋株式会社 抑制表皮增厚的保健食品

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005046133A (ja) * 2003-10-20 2005-02-24 Medicaraise Corp ヒアルロン酸とデルマタン硫酸を含有する健康食品
JP2009051877A (ja) * 2007-08-23 2009-03-12 Q P Corp 新規なヒアルロン酸および/またはその塩、ならびにこれを用いた食品組成物および経口医薬品組成物、ならびに該ヒアルロン酸および/またはその塩を有効成分として含有する経口用皮膚改善剤または経口用皮膚含水量増加剤
JP2013180989A (ja) * 2012-03-02 2013-09-12 Q P Corp ヒアルロン酸合成促進剤
JP2013180988A (ja) * 2012-03-02 2013-09-12 Q P Corp 経口用光老化抑制剤
JP2013180990A (ja) * 2012-03-02 2013-09-12 Q P Corp コラーゲン合成促進剤

Similar Documents

Publication Publication Date Title
WO2014108846A3 (en) Soothing cosmetic composition based on salicylic acid
IT1400982B1 (it) Collirio osmotico trans-epiteliale per la cura del cheratocono.
IT1402907B1 (it) Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose.
WO2012085523A3 (en) Skin sanitizer compositions comprising alcohol based emulsion
IN2014DN09434A (enExample)
ZA201401678B (en) Novel distributed 3,4-diamino-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
JP2014530840A5 (enExample)
CO6940374A2 (es) Composiciones, usos y métodos para tratamiento de trastornos y enfermedades metabólicas
CL2014000050A1 (es) Composicion farmaceutica en forma de solucion que comprende apomorfina, un codisolvente micible en agua, un antioxidante y agua, en la que el ph es superior a 4; procedimiento para fabricarla; y su uso como solucion inyectable en el tratamiento de la enfermedad de parkinson.
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
HK1206621A1 (en) Formulations comprising idebenone, n-acetyl-s-farnesyl-l-cysteine and ergothioneine and uses thereof
PH12015500585A1 (en) Modified hyaluronic acid derivatives and use thereof
EP3138850B8 (en) Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid
CL2014003484A1 (es) Uso de nalmefeno en la reduccion del consumo de alcohol en un paciente con dependencia del alcohol; composicion farmaceutica oral; combinacion farmaceutica.
MX371525B (es) Composicion para el cuidado bucal.
LT2988792T (lt) Farmacinės kompozicijos, turinčios hialurono rūgšties, skirtos naudoti "juodojo disko" ligos (tarpslankstelinio disko degeneracijos) gydymui
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина
WO2013066481A3 (en) Cosmetic use of n-heteroarylbisamide analogs and related compounds
UA62758U (ru) Препарат "аромадент плюс" в виде геля для лечения и профилактики воспалительных заболеваний пародонта
JP2013147480A5 (enExample)
PL2431356T3 (pl) Peptydomimetyki będące pochodnymi metioniny i ich zastosowanie w ochronie mitochondriów komórek skóry
JP2015027996A5 (enExample)
JO2965B1 (en) The use of ferroxine in the treatment or prevention of malaria
NO20110300A1 (no) Anvendelse av en vandig kalsiumhydroksidoppløsning for å redusere sideeffektene ved bleking av tenner, og et tannblekingssett